3 min read

EverHint Crossovers – SMA 20/50, EMA 10 + Price + MACD, EMA 10/30 – Top 15 Buy and Top 10 Sell Signals for Oct 09, 2026

25 signals (from 110 total). Technology leads (19). price range $10-$800. 1 with insider buying. 3 with insider selling.

Excerpt: 25 signals (from 110 total). Technology leads (19). price range $10-$800. 1 with insider buying. 3 with insider selling.

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (5 of 5)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 ASAN Asana, Inc. Technology $10.07 — $2.4B
2 CBZ CBIZ, Inc. Industrials $54.82 — $2.9B
3 CHEF The Chefs' Warehouse, ... Consumer Defensive $114.32 — $4.7B
4 LIND Lindblad Expeditions H... Consumer Cyclical $35.82 — $2.4B
5 SCCO Southern Copper Corpor... Basic Materials $209.21 — $174.6B

🔴 Sell Signals (5 of 16)

# Ticker Company Sector Price Insider MCap
1 CACI CACI International Inc Technology $610.65 — $13.5B
2 DIS The Walt Disney Company Communication Services $108.05 — $187.6B
3 DNOW Dnow Inc. Industrials $15.57 — $2.8B
4 DXPE DXP Enterprises, Inc. Industrials $180.92 — $2.8B
5 ING ING Groep N.V. Financial Services $33.37 — $95.3B

EMA 10 + Price + MACD

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line
  • Sell: Price < EMA10 AND MACD line crosses below signal line
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

🟢 Buy Signals (5 of 33)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 ABT Abbott Laboratories Healthcare $99.62 — $172.4B
2 ALC Alcon Inc. Healthcare $64.11 — $31.3B
3 AMR Alpha Metallurgical Re... Basic Materials $181.57 — $2.3B
4 ASND Ascendis Pharma A/S Healthcare $229.23 — $14.2B
5 ATAT Atour Lifestyle Holdin... Consumer Cyclical $33.07 — $4.6B

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (5 of 40)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 ACHC Acadia Healthcare Comp... Healthcare $29.25 — $2.7B
2 ADSK Autodesk, Inc. Technology $235.35 — $49.7B
3 AIG American International... Financial Services $77.03 — $40.8B
4 AMZN Amazon.com, Inc. Consumer Cyclical $262.43 — $2823.0B
5 BEKE KE Holdings Inc. Real Estate $17.84 — $19.7B

🔴 Sell Signals (5 of 16)

# Ticker Company Sector Price Insider MCap
1 AEHR Aehr Test Systems Technology $84.64 — $2.8B
2 AMKR Amkor Technology, Inc. Technology $49.12 — $12.2B
3 BLSH Bullish Technology $32.59 — $4.9B
4 CAT Caterpillar Inc. Industrials $800.47 — $368.7B
5 CNH CNH Industrial N.V. Industrials $11.39 — $14.1B

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.